Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

927 Traction-Assisted Endoscopic Submucosal Dissection Reduces Procedure Time and Risk of Adverse Events: A Meta-Analysis

View through CrossRef
INTRODUCTION: Endoscopic submucosal dissection (ESD) is superior to endoscopic mucosal resection (EMR) for treatment of superficial gastrointestinal neoplasia because it is associated with increased en bloc resection and lower rates of local recurrence. However, ESD is a technically demanding procedure with increased procedure time and has potential for serious adverse events. To overcome the procedural difficulty of ESD, Various traction methods such as clip-line method, clip and snare method and internal traction method, have been developed to provide countertraction to expose the dissection plane and allow safe and effective submucosal dissection. A number of studies have compared efficacy of traction-assisted ESD (T-ESD) and conventional ESD (C-ESD) but results are conflicting. We conducted a meta-analysis to assess the efficacy of T-ESD. METHODS: All clinical studies published up to April 2019 comparing the efficacy and safety of T-ESD and C-ESD were identified using electronic bibliographic searches of PubMed, Medline, EMBASE, The Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register), and Web of Science (Science and Social Science Citation Index). Outcomes of interests included procedure time (minutes), rate of en bloc and R0 resections, and rates of adverse events (bleeding and perforation). Random effect model was used to calculate pooled mean difference (MD) for continuous variables and Odds ratios (ORs) for categorical variables. RESULTS: Of 621 articles identified, 18 studies [939 T-ESD and 963 C-ESD procedures] met inclusion criteria for final analysis [6 randomized controlled trials and 12 observational studies]. Overall, T-ESD significantly reduced procedure time (MD = - 16.63 min, 95% CI - 24.65 to - 8.60, P < 0.0001, I 2 = 68) and complication rates (OR = 0.56, 95% CI 0.36 - 0.87, P = 0.009, I 2 = 0) compared to C-ESD. En bloc resection and R0 resection rates were similar in both groups (OR = 2.36; 95% CI 0.58 - 9.55; P = 0.23, I 2 = 0 and OR = 1.45; 95% CI 0.76 - 2.77; P = 0.25, I 2 = 0; respectively). No publication bias was detected by funnel plot. CONCLUSION: Traction techniques facilitate submucosal dissection, reduce procedure time and improve its safety. These techniques are simple and can be performed using readily available accessories in the endoscopy unit. Application of traction method improves feasibility of ESD and may enable the widespread use of ESD in the West.
Title: 927 Traction-Assisted Endoscopic Submucosal Dissection Reduces Procedure Time and Risk of Adverse Events: A Meta-Analysis
Description:
INTRODUCTION: Endoscopic submucosal dissection (ESD) is superior to endoscopic mucosal resection (EMR) for treatment of superficial gastrointestinal neoplasia because it is associated with increased en bloc resection and lower rates of local recurrence.
However, ESD is a technically demanding procedure with increased procedure time and has potential for serious adverse events.
To overcome the procedural difficulty of ESD, Various traction methods such as clip-line method, clip and snare method and internal traction method, have been developed to provide countertraction to expose the dissection plane and allow safe and effective submucosal dissection.
A number of studies have compared efficacy of traction-assisted ESD (T-ESD) and conventional ESD (C-ESD) but results are conflicting.
We conducted a meta-analysis to assess the efficacy of T-ESD.
METHODS: All clinical studies published up to April 2019 comparing the efficacy and safety of T-ESD and C-ESD were identified using electronic bibliographic searches of PubMed, Medline, EMBASE, The Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register), and Web of Science (Science and Social Science Citation Index).
Outcomes of interests included procedure time (minutes), rate of en bloc and R0 resections, and rates of adverse events (bleeding and perforation).
Random effect model was used to calculate pooled mean difference (MD) for continuous variables and Odds ratios (ORs) for categorical variables.
RESULTS: Of 621 articles identified, 18 studies [939 T-ESD and 963 C-ESD procedures] met inclusion criteria for final analysis [6 randomized controlled trials and 12 observational studies].
Overall, T-ESD significantly reduced procedure time (MD = - 16.
63 min, 95% CI - 24.
65 to - 8.
60, P < 0.
0001, I 2 = 68) and complication rates (OR = 0.
56, 95% CI 0.
36 - 0.
87, P = 0.
009, I 2 = 0) compared to C-ESD.
En bloc resection and R0 resection rates were similar in both groups (OR = 2.
36; 95% CI 0.
58 - 9.
55; P = 0.
23, I 2 = 0 and OR = 1.
45; 95% CI 0.
76 - 2.
77; P = 0.
25, I 2 = 0; respectively).
No publication bias was detected by funnel plot.
CONCLUSION: Traction techniques facilitate submucosal dissection, reduce procedure time and improve its safety.
These techniques are simple and can be performed using readily available accessories in the endoscopy unit.
Application of traction method improves feasibility of ESD and may enable the widespread use of ESD in the West.

Related Results

Effectiveness and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction
Effectiveness and safety of endoscopic submucosal dissection for intraepithelial neoplasia of the esophagogastric junction
Background Endoscopic submucosal dissection of the esophagogastric junction is the most difficult gastric and esophageal dissection procedure. No reports of endoscopic ...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Effect of cervical suspensory traction in the treatment of severe cervical kyphotic deformity
Effect of cervical suspensory traction in the treatment of severe cervical kyphotic deformity
ObjectiveThis study aimed to investigate a new noninvasive traction method on the treatment of severe cervical kyphotic deformity.MethodsThe clinical data of patients with severe c...
Dynamic Parallel Traction's Impact on Femoral Neck Fracture Biomechanics: A 3D Finite Element Study
Dynamic Parallel Traction's Impact on Femoral Neck Fracture Biomechanics: A 3D Finite Element Study
Abstract Objective: This study aims to investigate the impact of dynamic parallel traction on the biomechanical characteristics of femoral neck fractures, with the goal of ...
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Gastric Pyloric Schwannoma: A Case Report and Review of the Literature
Abstract Introduction Schwannomas are slow-growing, subclinical neoplasms rarely found in the gastrointestinal tract. This study reports a schwannoma in the pyloric region of the s...
Evaluation of Postoperative Outcomes of Endoscopic Submucosal Dissection in Primary Gastric Cancer
Evaluation of Postoperative Outcomes of Endoscopic Submucosal Dissection in Primary Gastric Cancer
Background: Few studies have investigated the changes in postoperative quality of life; serum Livin, epidermal growth factor (EGF), and interleukin (IL)-8 levels; and traumatic str...
Endoscopic Submucosal Dissection in Patients with Ulcerative Colitis
Endoscopic Submucosal Dissection in Patients with Ulcerative Colitis
Patients with ulcerative colitis have an increased risk of developing colorectal cancer. This risk has been estimated to reach about 7% at 20 years of disease, 7–14% at 25 years, a...

Back to Top